Skip to main content
SpringerLink
Log in

Oral Health and Survivorship: Late Effects of Cancer and Cancer Therapy

  • Chapter
  • First Online:
The MASCC Textbook of Cancer Supportive Care and Survivorship

Abstract

Oral complications of cancer and cancer therapy during and following therapy affect oral function, quality of life (QOL), and general health. Prevention and management is required throughout the course of the disease from diagnosis to survivorship. While the impact of acute oral complications in cancer patients is generally recognized, the potential negative impact of late oral health problems on symptom burden, oral function, and overall health is underappreciated. As survivorship increases, there has been increased interest in late treatment effects. This chapter reviews late effects of cancer therapy with a focus on head and neck cancer patients and stem cell transplantation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Epstein JB, Emerton S, Kolbinson DA, Le N, Phillips N, Stevenson-Moore P, Osoba D. Quality of life and oral function following radiotherapy for head and neck cancer. Head Neck. 1999;21:1–11.

    Article  CAS  PubMed  Google Scholar 

  2. Abendstein H, Nordgren M, Boysen M, et al. Quality of life and head and neck cancer: a 5 year prospective study. Laryngoscope. 2005;115(12):2183–92.

    Article  PubMed  Google Scholar 

  3. Nordgren M, Hammerlid E, Bjordal K, Ahlner-Elmqvist M, Boysen M, Jannert M. Quality of life in oral carcinoma: a 5-year prospective study. Head Neck. 2008;30(4):461–70.

    Article  PubMed  Google Scholar 

  4. de Graeff A, de Leeuw JR, Ros WJ, Hordijk GJ, Blijham GH, Winnubst JA. Long-term quality of life of patients with head and neck cancer. Laryngoscope. 2000;110(1):98–106.

    Article  PubMed  Google Scholar 

  5. Oates JE, Clark JR, Read J, Reeves N, Gao K, Jackson M, et al. Prospective evaluation of quality of life and nutrition before and after treatment for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 2007;133:533–40.

    Article  PubMed  Google Scholar 

  6. We Y, Hu WH, Xia YF, Ma J, Liu MZ, Cui NJ. Quality of life of nasopharyngeal carcinoma survivors in mainland China. Qual Life Res. 2007;16:65–74.

    Article  Google Scholar 

  7. Jensen SB, Mouridsen HT, Bergmann OJ, Reibel J, Brunner RN, Nauntofle B. Oral mucosal lesions, microbial changes and taste disturbances induced by adjuvant chemotherpay in breast cancer patients. Oral Surg Oral Med Oral Pathol Radiol Endod. 2008;106:217–26.

    Article  Google Scholar 

  8. Woo SB, Sonis ST, Monopoli MM, Sonis AL. A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients. Cancer. 1993;72(5):1612–7.

    Article  CAS  PubMed  Google Scholar 

  9. Brand HS, Bots CP, Raber-Durlacher JE. Xerostomia and chronic oral complications among patients treated with haematopoietic stem cell transplantation. Br Dent J. 2009;207(9):E17; discussion 428–9.

    Article  CAS  PubMed  Google Scholar 

  10. Epstein JB, Raber-Durlacher JE, Wilkins A, Chavarria MG, Myint H. Advances in hematologic stem cell transplant: an update for oral health care providers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107(3):301–12.

    Article  PubMed  Google Scholar 

  11. Flowers MED, Parker PM, Johnston LJ, et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood. 2002;100:415–9.

    Article  CAS  PubMed  Google Scholar 

  12. Kruse AL, Gratz KW. Oral carcinoma after hematopoietic stem cell transplantation-a new classification based on a literature review over 30 years. Head Neck Oncol. 2009;1:29.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Imanguli MM, Alevizos I, Brown R, Pavletic SZ, Atkinson JC. Oral graft versus host disease. Oral Dis. 2008;14:396–412.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Wasserman TH, Brizel DM, Henke M, Monnier A, et al. Influence of intravenous amifostine on xerostomia, tumore control and survival after radiotherapy for head and neck cancer: a two year follow-up. Int J Radiat Oncol Biol Phys. 2005;63:985–90.

    Article  CAS  PubMed  Google Scholar 

  15. Buentzel J, Glatzel M, Mucke R, Micke O, Bruns F. Influence of amifostine on late radiation-toxicity in head and neck cancer: a follow-up study. Anticancer Res. 2007;27:1953–6.

    CAS  Google Scholar 

  16. Worthington HV, Clarkson JE, Eden OB. Interventions for preventing oral mucositis for patients receiving cancer treatment. Cochrane Data Base Systematic Rev. 2007;4:CD000978.

    Google Scholar 

  17. Law A, Kennedy T, Pellitteri P, Wood C, Christie D, Yumen O. Efficacy and safety of subcutaneous amifostine in minimizing radiation-induced toxicities in patients receiving combined-modality treatment for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol PhysInt J Radiat Oncol Biol Phys. 2007;69(5):1361–8.

    Article  CAS  Google Scholar 

  18. Scarantino C, LeVeque F, Swann RS, White R, Schulsinger A, et al. Effect of pilocarpine during radiation therapy: results of RTOG 97-09a phase III randomized study in head and neck cancer patients. J Support Oncol. 2006;4:252–8.

    CAS  PubMed  Google Scholar 

  19. Burlage FR, Roesink JM, Kampinga HH, Coppes RP, Terhaard C, Langendijk JA, van Luijk P, Stokman MA, Vissink A. Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study. Int J Radiat Oncol Biol Phys. 2008;70(1):14–22.

    Article  CAS  PubMed  Google Scholar 

  20. Chambers MS, Jones CU, Biel MA, et al. Open-label, long-term safety study of cevimeline in the treatment of post-irradiation xerostomia. Int J Radiat Oncol Biol Phys. 2007;69(5):1369–76.

    Article  CAS  PubMed  Google Scholar 

  21. Chambers MS, Posner M, Jones CU, et al. Cevimeline for the treatment of post-irradiation xerostomia in patients with head and neck cancer. Int J Radiat Oncol Biol PhysInt J Radiat Oncol Biol Phys. 2007;68(4):1102–9.

    Article  CAS  Google Scholar 

  22. Jaguar GC, Pereira Lima EN, Kowalski LP, Pellizzon AC, Carvalho AL, Boccaletti KW, Alves FA. Double blind randomized prospective trial of bethanechol in the prevention of radiation-induced salivary glan dysfunction in head and neck cancer patients. Radiother Oncol. 2015;115:253–6.

    Article  CAS  PubMed  Google Scholar 

  23. Seikaly H, Jha N, Harris JR, Barnaby P, Liu R, Williams D, McGaw T, Reiger J, Wolfaardt J, Hanson J. Long-term outcomes of submandibular gland transfer for prevention of postradiation xerostomia. Arch Otolaryngol. 2004;130(8):956–61.

    Article  Google Scholar 

  24. Wu F, Li C. Salivary gland transfer to prevent radiation-induced xerostomia: a systematic review and meta-analysis. Oral Oncol. 2014;50:77–83.

    Article  Google Scholar 

  25. Henson BS, Inglehart MR, Eisbruch A, Ship JA. Preserved salivary output and xerostomia related quality-of-life in head and neck cancer patients receiving parotid-sparing radiotherapy. Oral Oncol. 2001;37(1):84–93.

    Article  CAS  PubMed  Google Scholar 

  26. Lin A, Kim HM, Terrell JE, Dawson LA, Ship JA, Eisbruch A. Quality of life after parotid sparing IMRT for head and neck cancer: a prospective longitudinal study. Int J Radiat Oncol Biol Phys. 2003;57(12):61–70.

    Article  PubMed  Google Scholar 

  27. Pacholke HD, Amdur RJ, Morris CG, et al. Late xerostomia after intensity-modulated radiation therapy versus conventional radiotherapy. Am J Clin Oncol. 2005;28(4):351–8.

    Article  PubMed  Google Scholar 

  28. Schubert MM, Correa ME. Oral graft versus host disease. Dent Clin N Am. 2008;52:79–109.

    Article  PubMed  Google Scholar 

  29. Epstein JB, Elad S, Eliav E, Jurevic R, Benoliel R. Orofacial pain in cancer part II: clinical perspectives and management. J Dent Res. 2007;86:506–18.

    Article  CAS  PubMed  Google Scholar 

  30. Yamashita H, Nakagawa K, Hosoi Y, Kurokawa A, Fukuda Y, Matsumoto I, Misaka T, Abe K. Umami taste dysfunction in patients receiving radiotherapy for head and neck cancer. Oral Oncol. 2009;45:e19–e23.

    Article  Google Scholar 

  31. Shi HB, Masuda M, Umezaki T, Kuratomi Y, Yamamoto T, Komiyama S. Irradiation impairment of umami taste in patients with head and neck cancer. Auris Nasus Larynx. 2004;31:401–6.

    Article  PubMed  Google Scholar 

  32. Epstein JB, Smutzer G, Doty RL. Understanding the impact of taste changes in oncology care. Support Care Cancer. 2016;24(4):1917–31.

    Article  PubMed  Google Scholar 

  33. Peregrin T. Improving taste sensation in patients who have undergone chemotherapy or radiation therapy. J Am Diet Assoc. 2006;106:15–40.

    Article  Google Scholar 

  34. Yamahita H, Nakagawa K, Nakamura N, Abe K, Asakage T, et al. Relation between acute and late irradiation impairment of four basic tastes and irradiated tongue volume in patients with head and neck cancer. Int J Radiat Oncol Biol Phys. 2006;66:1422–9.

    Article  Google Scholar 

  35. Sandow PL, Hejrat-Yazdi M, Heft MW. Taste loss and recovery following radiation therapy. J Dent Res. 2006;85:608–11.

    Article  CAS  PubMed  Google Scholar 

  36. Halyard MY, Jatoi A, Sloan JA, Bearden JD 3rd, Vora SA, et al. Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the north central cancer treatment group (N01C4). Int J Radiat Oncol Biol Phys. 2007;67:1318–22.

    Article  CAS  PubMed  Google Scholar 

  37. Thorne T, Olson K, Wismer W. A state-of-the-art review of the management and treatment of taste and smell alterations in adult oncology patients. Support Care Cancer. 2015;23(9):2843–51.

    Article  PubMed  Google Scholar 

  38. Gomez DR, Zhung JE, Bomez J, Chan K, Wu AJ, et al. Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers. Int J Radiat Oncol Biol Phys. 2009;73:1096–103.

    Article  PubMed  Google Scholar 

  39. Hsiung CY, Huang EY, Ting HM, Huang HY. Intensity-modulated radiotherapy for nasopharyngeal carcinoma: the reduction of radiation-induced trismus. Br J Radiol. 2008;81:809–14.

    Article  Google Scholar 

  40. Dijkstra DU, Kalk WW, Roodenburg JL. Trismus in head and neck oncology: a systematic review. Oral Oncol. 2004;40:879–89.

    Article  CAS  PubMed  Google Scholar 

  41. Louse Kent M, Brennan MT, Noll JL, Fox PC, Burri SH, et al. Radiation-induced trismus in head and neck cancer patients. Support Care Cancer. 2008;16:305–9.

    Article  Google Scholar 

  42. Shulmann DH, Shipman B, Willis FB. Treating trismus with dynamic splinting: a cohort case series. Adv Ther. 2008;25:9–16.

    Article  Google Scholar 

  43. Bhrany AD, Izzard M, Wood AJ, Futran ND. Coronoidectomy for the treatment of trismus in head and neck cancer patients. Laryngoscope. 2007;117:1052–6.

    Article  Google Scholar 

  44. Nieder C, Zimmermann FB, Adam M, Mools M. The role of pentoxifylline as a modifier of radiation therapy. Cancer Treat Rev. 2005;44:8–55.

    Google Scholar 

  45. Hartl DM, Cohen M, Julieron M, Marandas P, Janot F, Bourhis J. Botulinum toxin for radiation-induced facial pain and trismus. Otolaryngol Head Neck Surg. 2008;138:459–63.

    Article  PubMed  Google Scholar 

  46. Jackson LK, Deng J, Ridner SH, Gilbert J, Dietrich MS, Murphy BA. Preliminary testing of a patient-reported outcome measure for recurrent or metastatic head and neck cancer. Am J Hosp Palliat Care. 2016;33(4):313–20.

    Article  PubMed  Google Scholar 

  47. Loesche WJ. Microbiology and treatment of halitosis. Curr Infect Dis Rep. 2003;5:220–6.

    Article  PubMed  Google Scholar 

  48. Lyons A, Ghazali N. Osteoradionecrosis of the jaws: current understanding of its pathophysiology and treatment. Brit J Oral Max Surg. 2008;46:653–60.

    Article  Google Scholar 

  49. Migliorati CA, Siegel MA, Elting LS. Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment. Lancet Oncol. 2006;7:508–14.

    Article  CAS  PubMed  Google Scholar 

  50. Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. American association of oral and maxillofacial surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg. 2007;65:369–76.

    Article  Google Scholar 

  51. Teng MS, Futran ND. Osteoradionecrosis of the mandible. Curr Opin Otolaryngol Head Neck Surg. 2005;13:217–21.

    Article  PubMed  Google Scholar 

  52. Pitak-Arnnop P, Sader R, et al. Management of osteoradionecrosis of the jaws: an analysis of evidence. Eur J Surg Oncol. 2008;34(10):1123–34.

    Article  CAS  PubMed  Google Scholar 

  53. Glicksman JT, Khalili S, Fung K, Parnes L, Agrawal S. Pentoxifylline-tocopherol-clodronate combination: a novel treatment for osteoradionecrosis of the temporal bone. Head Neck. 2015;37:E191–3.

    Article  PubMed  Google Scholar 

  54. Patel V, Gadiwalla Y, Sassoon I, Sproat C, Kwok J, McGurk M. Use of pentoxifylline and tocopherol in the management of osteoradionecrosis. Br J Oral Maxillofac Surg. 2016;54:342–5.

    Article  PubMed  Google Scholar 

  55. Patel V, Gadiwalla Y, Sassoon I, Sproat C, Kwok J, McGurk M. Prophylactic use of pentoxifylline and tocopherol in patients who require dental extractions after radiotherapy for cancer of the head and neck. Br J Oral Maxillofac Surg. 2016;54:547–50.

    Article  PubMed  Google Scholar 

  56. Landgren O, Gilbert ES, Rizzo JD, Socie G, Banks PM, et al. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood. 2009;113:6263–4.

    Article  Google Scholar 

  57. Martins F, de Oliveira MA, Wang Q, Sonis S, Gallottini M, George S, Treister N. A review of oral toxicity associated with mTOR inhibitor therapy in cancer patients. Oral Oncol. 2013;49(4):293–8.

    Article  CAS  PubMed  Google Scholar 

  58. Yuan A, Kurtz SL, Barysauskas CM, Pilotte AP, Wagner AJ, Treister NS. Oral adverse events in cancer patients treated with VEGFR-directed tyrosine kinase inhibitors. Oral Oncol. 2015;51(11):1026–33.

    Article  CAS  Google Scholar 

  59. Watters AL, Epstein JB, Agulnik M. Oral complications of targeted cancer therapies: a narrative literature review. Oral Oncol. 2011;47(6):441–8.

    Article  CAS  PubMed  Google Scholar 

  60. Budach W, Bolke E, Homey B. Severe cutaneous reaction during radiation therapy with concurrent cetuximab. N Engl J Med. 2007;357:514–5.

    Article  CAS  PubMed  Google Scholar 

  61. Mesia R, Vilajosana E, Lozano A, Esteller L, Silvia V. Management of cutaneous toxicity and radiation dermatitis in patients with squamous cancer of the head and neck undergoing concurrent treatment with cetuximab and radiotherapy. J Cancer Sci Ther. 2009;1:28–33.

    Article  Google Scholar 

  62. Jackson LK, Johnson DB, Sosman JA, Murphy BA, Epstein JB. Oral health in oncology: impact of immunotherapy. Support Care Cancer. 2015;23(1):1–3.

    Article  PubMed  Google Scholar 

  63. Oral Complications of Cancer Treatment: What the Oncology Team Can Do. NIH Publication No. 09-4360.

    Google Scholar 

  64. Kumar N, Brooke A, Burke M, John R, O’Donnell A, Soldani F. The oral management of oncology patients requiring radiotherapy, chemotherapy and/or bone marrow transplantation. Facul Dent J. 2013;4(4):200–3.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Health System, Los Angeles, CA, USA

    Joel B. Epstein

  2. Vanderbilt University Medical Center, Nashville, TN, USA

    Derek K. Smith & Barbara A. Murphy

Authors
  1. Joel B. Epstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Derek K. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Barbara A. Murphy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joel B. Epstein .

Editor information

Editors and Affiliations

  1. University of South Australia, Adelaide, SA, Australia

    Ian Olver

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Epstein, J.B., Smith, D.K., Murphy, B.A. (2018). Oral Health and Survivorship: Late Effects of Cancer and Cancer Therapy. In: Olver, I. (eds) The MASCC Textbook of Cancer Supportive Care and Survivorship. Springer, Cham. https://doi.org/10.1007/978-3-319-90990-5_40

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-90990-5_40

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-90989-9

  • Online ISBN: 978-3-319-90990-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation